Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents

    ... The erythroid response rate was lower in refractory cytopenia with multilineage dysplasia (27% vs. 60%) and tended to be higher ...

    Research Article last updated 04/24/2012 - 2:47pm.

  2. Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes.

    ... anemia with excess blasts or refractory cytopenia with multilineage dysplasia had a higher chance to be treated ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Eltrombopag and improved hematopoiesis in refractory aplastic anemia

    ... to immunosuppression, with persistent, severe cytopenia and a profound deficit in hematopoietic stem cells and ...

    Research Article last updated 07/31/2012 - 2:24pm.

  4. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes

    ... bicytopenia, or any persistent and unexplained isolated cytopenia (and particularly unexplained macrocytic anemia) should be ...

    Research Article last updated 07/31/2012 - 1:03pm.

  5. Therapeutic modalities for patients with lower-risk myelodysplastic syndromes: current options and future directions.

    ... Anemia , the most common symptomatic cytopenia , warrants treatment in an attempt to eliminate transfusion ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. North American Pediatric Aplastic Anemia Consortium Symposium

    ... difficult distinction of SAA from refractory cytopenia of childhood (RCC), a subtype of myelodysplastic syndrome (MDS) ...

    Page last updated 10/31/2013 - 4:06pm.

  7. WHO 2008 Classifications / Scoring

    ... Risk Stratification and Treatment Options . Blood Cytopenia - None - Anemia Neutropenia Thrombocytopenia 2 ...

    Webform last updated 10/14/2013 - 1:20pm.